{"id":"clm_A6F2CE4E7D05","entity":"abbvie","predicate":"shares_outstanding","value":"1,765,537,421 shares","value_json":{"fp":"Q3","fy":2023,"accn":"0001551152-23-000045","form":"10-Q","filed":"2023-11-06","period":"Q3 FY2023","concept":"dei:EntityCommonStockSharesOutstanding"},"valid_from":"2023-10-27","valid_to":"2024-01-31","published":"2023-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"AbbVie shares outstanding: 1,765,537,421 shares\", as of 2023-10-27 (until 2024-01-31). Claim clm_A6F2CE4E7D05, https://asof.is/claim/clm_A6F2CE4E7D05, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1551152/000155115223000045/0001551152-23-000045-index.htm.","url":"https://asof.is/claim/clm_A6F2CE4E7D05","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_89944DBAFE9E","supersedes":["clm_6CE3680212C4"],"first_seen_at":"2026-11-08T15:33:08.46324+00:00","updated_at":"2026-11-08T15:33:12.504986+00:00","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1551152/000155115223000045/0001551152-23-000045-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2023","published_at":"2023-11-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2023, filed 2023-11-06"},"legend":{"dates":"valid_from: when the claim took effect (a period figure: the day its period closed). published: the earliest day a source on the record published it (a filing's filing date, a post's date; null when no source carries one). recorded: the day AsOf first held it. A figure can take effect weeks before it is published.","citation":"citation: how to cite the row (plain: one sentence with the value, its as-of date, the claim id and URL, the day answered and the primary source; url: the claim page; accessed: the day answered). APA and BibTeX forms are on the claim page.","why_not":{},"checked_by":{"sec-filing":"parsed from the SEC filing"}}}